IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $23,066,000 | -4.6% | 4,825,543 | -10.2% | 0.02% | 0.0% |
| Q2 2022 | $24,174,000 | -7.7% | 5,372,065 | -2.4% | 0.02% | +15.0% |
| Q1 2022 | $26,194,000 | -40.0% | 5,502,843 | -6.5% | 0.02% | -33.3% |
| Q4 2021 | $43,681,000 | +28.9% | 5,886,930 | -1.5% | 0.03% | +25.0% |
| Q3 2021 | $33,878,000 | -13.7% | 5,975,009 | +0.3% | 0.02% | -11.1% |
| Q2 2021 | $39,244,000 | -20.7% | 5,955,041 | -2.5% | 0.03% | -27.0% |
| Q1 2021 | $49,480,000 | +11.3% | 6,108,685 | -11.4% | 0.04% | +8.8% |
| Q4 2020 | $44,459,000 | +65.8% | 6,892,928 | -7.5% | 0.03% | +47.8% |
| Q3 2020 | $26,822,000 | -24.7% | 7,450,492 | -3.8% | 0.02% | -28.1% |
| Q2 2020 | $35,617,000 | +25.7% | 7,742,804 | -6.8% | 0.03% | +3.2% |
| Q1 2020 | $28,327,000 | -34.4% | 8,307,064 | -8.2% | 0.03% | -13.9% |
| Q4 2019 | $43,173,000 | +72.1% | 9,050,869 | -12.7% | 0.04% | +63.6% |
| Q3 2019 | $25,082,000 | +10.5% | 10,364,463 | -0.9% | 0.02% | +10.0% |
| Q2 2019 | $22,706,000 | -5.5% | 10,463,661 | +18.0% | 0.02% | -4.8% |
| Q1 2019 | $24,039,000 | -40.4% | 8,870,628 | +5.5% | 0.02% | -48.8% |
| Q4 2018 | $40,351,000 | -47.3% | 8,406,481 | +4.0% | 0.04% | -37.9% |
| Q3 2018 | $76,554,000 | -14.2% | 8,083,851 | -11.8% | 0.07% | -9.6% |
| Q2 2018 | $89,176,000 | -11.5% | 9,165,030 | -4.3% | 0.07% | -23.2% |
| Q1 2018 | $100,776,000 | +42.0% | 9,579,449 | -13.5% | 0.10% | +43.9% |
| Q4 2017 | $70,967,000 | -18.9% | 11,071,365 | -3.3% | 0.07% | -21.4% |
| Q3 2017 | $87,559,000 | -4.3% | 11,445,611 | -11.1% | 0.08% | -6.7% |
| Q2 2017 | $91,518,000 | +63.9% | 12,871,696 | -10.8% | 0.09% | +60.7% |
| Q1 2017 | $55,840,000 | +102.1% | 14,428,856 | +6.5% | 0.06% | +86.7% |
| Q4 2016 | $27,630,000 | -32.1% | 13,544,332 | -10.7% | 0.03% | -34.8% |
| Q3 2016 | $40,668,000 | -15.0% | 15,174,726 | -2.3% | 0.05% | -19.3% |
| Q2 2016 | $47,863,000 | -61.4% | 15,539,820 | +6.9% | 0.06% | -61.5% |
| Q1 2016 | $123,897,000 | -36.2% | 14,541,891 | +1.6% | 0.15% | -34.2% |
| Q4 2015 | $194,310,000 | +39.7% | 14,319,106 | -1.2% | 0.22% | +35.5% |
| Q3 2015 | $139,081,000 | -34.0% | 14,487,613 | -1.1% | 0.17% | -25.6% |
| Q2 2015 | $210,752,000 | +62.9% | 14,655,889 | +1.4% | 0.22% | +66.4% |
| Q1 2015 | $129,343,000 | +85.4% | 14,451,730 | +26.4% | 0.13% | +83.6% |
| Q4 2014 | $69,762,000 | -39.9% | 11,436,364 | +4.3% | 0.07% | -43.0% |
| Q3 2014 | $116,149,000 | -1.8% | 10,967,847 | +9.9% | 0.13% | -3.8% |
| Q2 2014 | $118,267,000 | -14.8% | 9,980,315 | +7.3% | 0.13% | -19.4% |
| Q1 2014 | $138,823,000 | +7.8% | 9,298,289 | +5.9% | 0.16% | +3.1% |
| Q4 2013 | $128,761,000 | +5.8% | 8,777,160 | +22.7% | 0.16% | -5.9% |
| Q3 2013 | $121,712,000 | +14.8% | 7,151,140 | +11.9% | 0.17% | +4.9% |
| Q2 2013 | $105,983,000 | – | 6,388,360 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |